Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Venus Concept ( (VERO) ) just unveiled an update.
On June 5, 2025, Venus Concept Inc. entered into an agreement to sell its Venus Hair Business to Meta Healthcare Group for $20 million in an all-cash transaction. This strategic move involves transferring hair restoration technologies and a manufacturing facility, with the transaction expected to close in the third quarter of 2025, pending regulatory approvals and other conditions.
Spark’s Take on VERO Stock
According to Spark, TipRanks’ AI Analyst, VERO is a Neutral.
Venus Concept faces significant financial and operational challenges, reflected in its weak financial performance and valuation metrics. While technical indicators and corporate events provide some optimism, they are insufficient to offset the underlying risks.
To see Spark’s full report on VERO stock, click here.
More about Venus Concept
Venus Concept Inc. operates in the medical aesthetics industry, focusing on hair restoration and hair transplant technologies. The company’s primary products and services include ARTAS and NeoGraft technologies, which are part of its Venus Hair Business.
Average Trading Volume: 1,161,294
Technical Sentiment Signal: Strong Sell
Current Market Cap: $3.4M
See more insights into VERO stock on TipRanks’ Stock Analysis page.